Crijns H J, Van Gelder I C, Tieleman R G, Brügemann J, De Kam P J, Gosselink A T, Bink-Boelkens M T, Lie K I
Department of Cardiology, University Hospital Groningen, The Netherlands.
Heart. 1997 Jan;77(1):56-61. doi: 10.1136/hrt.77.1.56.
To determine the long-term outcome of serial electrical cardioversion therapy in patients with chronic atrial flutter.
Prospective study, case series.
University hospital.
50 consecutive patients with chronic (> 24 hours) atrial flutter without a previous relapse on antiarrhythmic drugs.
Elective electrical cardioversion therapy, if necessary repeated, to obtain and keep patients in sinus rhythm. If the first cardioversion resulted in sinus rhythm, patients were not given antiarrhythmic drugs. Relapses were managed by repeated cardioversions then anti-arrhythmic drugs were used serially in a set sequence.
Maintenance of sinus rhythm.
Mean (SD) follow up was 3.5 (1.7) years. The first cardioversion was successful in 48 patients (96%). After a single shock and without antiarrhythmic drugs being used, 42% of the patients maintained sinus rhythm in the long-term. Only left atrial size was inversely related to the efficacy of one shock (P = 0.025). With serial cardioversion 90% of the patients were kept in sinus rhythm for 5 years. Univariate analysis showed that a long duration of arrhythmia and impaired cardiac function were both related to poor outcome. During follow up 3 patients died of progression of heart failure and another 5 died suddenly. None of these 5 patients was on antiarrhythmic drugs.
Electrical cardioversion was an effective and safe method of converting chronic atrial flutter to sinus rhythm. To maintain sinus rhythm, more than half of the patients required multiple shocks and prophylactic antiarrhythmic drugs. Sudden death was relatively frequent in the study population; the limited data available from this study suggest that such deaths were caused by the underlying disease and not drug related proarrhythmia.
确定慢性心房扑动患者序贯性电复律治疗的长期疗效。
前瞻性研究,病例系列。
大学医院。
50例连续的慢性(>24小时)心房扑动患者,此前未使用抗心律失常药物复发。
必要时进行择期电复律治疗,必要时重复进行,以使患者恢复并维持窦性心律。如果首次电复律导致窦性心律,则不给患者使用抗心律失常药物。复发通过重复电复律处理,然后按固定顺序依次使用抗心律失常药物。
维持窦性心律。
平均(标准差)随访3.5(1.7)年。首次电复律在48例患者(96%)中成功。在单次电击且未使用抗心律失常药物的情况下,42%的患者长期维持窦性心律。仅左心房大小与单次电击的疗效呈负相关(P = 0.025)。通过序贯性电复律,90%的患者维持窦性心律5年。单因素分析表明,心律失常持续时间长和心功能受损均与预后不良有关。随访期间,3例患者死于心力衰竭进展,另外5例突然死亡。这5例患者均未使用抗心律失常药物。
电复律是将慢性心房扑动转为窦性心律的有效且安全的方法。为维持窦性心律,超过一半的患者需要多次电击和预防性抗心律失常药物。在研究人群中猝死相对常见;本研究中有限的数据表明,此类死亡是由基础疾病引起的,而非药物相关的心律失常。